VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,794,553 | -58.6% | 511,692 | +8.4% | 0.00% | -62.5% |
| Q2 2023 | $11,576,444 | +3.9% | 471,930 | -1.4% | 0.01% | 0.0% |
| Q1 2023 | $11,136,696 | -10.0% | 478,586 | -2.1% | 0.01% | -11.1% |
| Q4 2022 | $12,373,148 | +33.5% | 488,864 | +1.7% | 0.01% | +28.6% |
| Q3 2022 | $9,268,000 | -22.9% | 480,746 | +1.9% | 0.01% | -22.2% |
| Q2 2022 | $12,021,000 | +1694.2% | 471,935 | +1713.0% | 0.01% | – |
| Q1 2022 | $670,000 | -38.2% | 26,031 | +0.6% | 0.00% | -100.0% |
| Q4 2021 | $1,084,000 | -35.2% | 25,878 | -32.7% | 0.00% | 0.0% |
| Q3 2021 | $1,673,000 | -10.5% | 38,440 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $1,870,000 | -9.0% | 39,558 | -1.3% | 0.00% | 0.0% |
| Q1 2021 | $2,056,000 | +92.9% | 40,098 | +0.7% | 0.00% | 0.0% |
| Q4 2020 | $1,066,000 | -0.8% | 39,811 | +27.2% | 0.00% | 0.0% |
| Q3 2020 | $1,075,000 | -16.4% | 31,307 | -0.3% | 0.00% | 0.0% |
| Q2 2020 | $1,286,000 | – | 31,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |